Clinical Trials Logo

Clinical Trial Summary

the aim of this study is to compare the effect of different modes of mechanical ventilation by using volume-controlled ventilation and pressure-controlled ventilation on cerebral blood flow monitored by cerebral oximetry during thoracoscopic surgeries in neonates.


Clinical Trial Description

The brain uses aerobic metabolism exclusively for energy production, so the brain is critically dependent on the nearly continuous delivery of oxygen to maintain cellular energy production. Normal cerebral blood flow is approximately 50 ml/100 gram of brain tissue/min. The brain represents 2% of the total body weight but it receives about 15% of the cardiac output. The brain is supplied by the circle of Willis which is formed of anastomosis between the internal carotid artery and the vertebro-basillar system. Monitoring of the CBF depends on either assessing the blood flow itself (e.g, radioactive substance and transcranial duplex) or assessing the oxygen delivery to the brain (e.g, cerebral oximetry and jugular bulb venous O2 saturation). CBF monitoring is an important parameter in both Intensive care unit and operation room in several aspects e.g, traumatic brain injury (TBI), acute stroke, carotid artery surgeries and cardiopulmonary bypass.

Cerebral oximetry is a continuous noninvasive technique that monitors the cerebral blood flow with several advantages over other CBF monitors including the ease of use and interpretation. It is painless and does not utilize ionizing radiation. The recordings provide real time information rather than single static measurements. Using the cerebral oximetry has few limitations including representing local rather than global CBF and absence of normal and cutoff values.

Thoracoscopic surgery was first introduced in 1910 and allowed a major advance in the field of thoracic surgery. Then with the improvement of the Instrumentation, thoracoscopic surgery started in the pediatric field in 1976 for simple procedures and now it is used predominantly in the pediatric thoracic surgery. The use of thoracoscope has many advantages over the open approach including using a smaller incision and reducing blood loss, postoperative pain, hospital stay and musculoskeletal deformities. Thoracoscope utilizes either one lung ventilation (OLV) or CO2 insufflation technique. In neonates the OLV technique is not suitable, so CO2 insufflation ( capnothorax ) is usually used.

Several studies were done and revealed the effect of thoracoscopy in neonate on CBF due to the effect of capnothorax which increases the intrathoracic pressure leading to decreased venous return and cardiac output, subsequently the CBF decreases, and with the increase of the insufflation pressure the decease in the CBF becomes more significant. Also the capnothorax may lead to hypercapnia which leads to changes in the CBF.

The incidence of newborn with congenital anomalies that require surgical procedure during the neonatal period is not low. With the increase of the survival rate, several studies proved that exposure of the neonates to surgery and anesthesia is associated with a higher risk of neuro-developmental delay in different aspects (sensory, motor, language, behavioral, cognitive, etc.) and thoracoscopic surgery is associated with higher risk due to the nature of the disease and the surgery. Using cerebral oximetry in addition to other routine monitors is of added value to maintain CBF within normal range to decrease the incidence of neurological injuries.

There are few studies showing that using different modes of mechanical ventilation affects CBF in neonates due to difference in several factors including effect on hemodynamics and airway pressure but there is no study comparing between volume controlled ventilation and pressure controlled ventilation. This research gap encourages us to do this study.

Preoperative assessment will be conducted on the patients the day before surgery including history taking from parents, full examination, routine laboratory investigations; in the form of CBC, coagulation profile, creatinine, urea, ALT, AST and radiological investigations; in the form of chest X-ray and echocardiography. the parents (guardians) will be consented to be included in the study & informed about the required fasting hours.

The patients enrolled in the study will be monitored all through the surgical procedure using pulse oximeter, non-invasive blood pressure and invasive blood pressure monitor (also for repeated arterial blood gases sampling), ECG, capnogram in addition to the cerebral oximetry.

Two infant probes of the cerebral oximetry will be applied to the patient on the both sides of the forehead and the monitor will display the cerebral oxygen saturation from the right and the left side of the brain digitally and in form of graph then the baseline reading of the cerebral oxygen saturation will be recorded before induction of anaesthesia.

Induction of general anaesthesia will be performed using a regimen of 1-2 µg/Kg fentanyl IV and 2-3mg/kg propofol IV then tracheal intubation is facilitated using atracurium 0.5 mg/kg IV. Ventilation will be mechanically controlled using the routine pressure-controlled mode, to maintain end tidal CO2 (ETCO2) between 30-35 mmHg.

Anaesthesia will be maintained using 1.6 % isoflurane that will be adjusted according to hemodynamics changes with top up doses of atracurium as required. After starting of gas insufflation using pressure of 4-6 mmHg and flow at 0.5 to 1.0 Liter/Minute, ventilation of patients will be modified according to the protocol of each group.

Recorded data will be analyzed using the statistical package for social sciences, version 20.0 (SPSS Inc., Chicago, Illinois, USA). Quantitative data will be expressed as mean± standard deviation (SD). Qualitative data will be expressed as frequency and percentage. The following tests will be done:

- Independent-samples t-test of significance will be used when comparing between two means.

- Mann Whitney U test: for two-group comparisons in non-parametric data.

- Chi-square (x2) test of significance will be used to compare proportions between qualitative parameters.

- The confidence interval is set to 95% and the margin of error accepted is set to 5%. So, the p-value is considered significant as the following:

- Probability (P-value) :- P-value <0.05 is considered significant. P-value <0.001 is considered as highly significant. P-value >0.05 is considered insignificant.

Sample size was calculated using G-power software. The cerebral oxygen saturation in neonates undergoing thoracoscopic surgery was derived from a previous study and was 73%±7 %.we assumed that different ventilation mode caused a difference of 10% in cerebral oxygen saturation .considering a study power of 80% and a p-value of 0.05 to be significant, the sample size was calculated to be 30 patients (15 in each group) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04507295
Study type Interventional
Source Cairo University
Contact Nasr M Abdallah, Assist. Prof
Phone 00201005223734
Email sief.nasr@yahoo.com
Status Not yet recruiting
Phase N/A
Start date August 8, 2020
Completion date November 15, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05100693 - Smart Removal for Congenital Diaphragmatic Hernia N/A
Recruiting NCT05450653 - Trial of FETO for Severe Congenital Diaphragmatic Hernia N/A
Terminated NCT04140669 - Automated Myocardial Performance Index Using Samsung HERA W10
Recruiting NCT05201144 - A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH) Phase 2
Not yet recruiting NCT06281717 - Fetal Endotracheal Occlusion (FETO) in Fetuses With Severe Congenital Diaphragmatic Hernia N/A
Recruiting NCT04429750 - Intact Cord Resuscitation in CDH N/A
Recruiting NCT03750266 - 3D Animation and Models to Aid Management of Fetal CDH
Not yet recruiting NCT05421676 - Fetal Endoscopic Tracheal Occlusion for CDH (CDH) N/A
Completed NCT01243229 - Genetic Analysis of Congenital Diaphragmatic Disorders
Recruiting NCT04583644 - Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH) N/A
Completed NCT03314233 - Delayed Cord Clamping for Congenital Diaphragmatic Hernia N/A
Recruiting NCT04114578 - Exploratory Observational Prospective Study in Neonatal and Pediatric Congenital Diaphragmatic Hernia
Completed NCT03666767 - Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
Recruiting NCT02986087 - Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia N/A
Recruiting NCT03674372 - Fetoscopic Endoluminal Tracheal Occlusion N/A
Active, not recruiting NCT05839340 - Neurally Adjusted Ventilatory Assist for Neonates With Congenital Diaphragmatic Hernias N/A
Enrolling by invitation NCT05962346 - Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia N/A
Withdrawn NCT04186039 - Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations N/A
Unknown status NCT01302977 - Fetal Tracheal Occlusion in Severe Diaphragmatic Hernia: a Randomized Trial Phase 2
Recruiting NCT03179371 - Proteomic Profiling for Congenital Diaphragmatic Hernia